GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
EBITDA Growth
-76.45%
Quarterly · Period ending:
GSK EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-76.45%period ending
Latest reported-76.45%period ending
GSK Quarterly EBITDA YoY % (15.13% → -76.45%)
Year-over-year change
High-resolution chart · PNG
GSK ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 25.7448% | |
| -10.5107% | |
| 179.8809% | |
| -50.6559% | |
| 71.7694% | |
| -32.8525% | |
| -12.6059% | |
| 10.6245% | |
| 9.0699% | |
| 4.1614% | |
| 5.6141% | |
| 2.7401% | |
| -65.2824% | |
| -5.5371% | |
| -85.7291% | |
| -19.5438% | |
| -3.7714% | |
| -3.8814% | |
| 52.7118% | |
| 162.6163% | |
| 33.1344% | |
| -0.2211% | |
| -35.5564% | |
| 5.1781% | |
| 16.0976% | |
| 17.2681% | |
| -17.0523% | |
| 0.6804% | |
| 23.9955% | |
| 42.5218% | |
| -12.5814% | |
| 34.7428% | |
| 10.0433% | |
| -12.0915% | |
| -82.9613% | |
| 41.1662% | |
| 45.6901% | |
| 51.1896% | |
| 0.663% | |
| 1.1727% | |
| -5.0081% | |
| -1.1386% | |
| -37.3714% | |
| 34.7755% | |
| 33.9174% | |
| 23.8511% | |
| -33.4835% | |
| 21.0888% | |
| 21.2534% | |
| 12.6426% | |
| -7.4044% | |
| 3.6234% | |
| 4.6565% | |
| 17.9922% | |
| -2.7041% | |
| 23.3627% | |
| 15.9959% | |
| 15.1279% |